Ondansetron associated with fatal arrythmias
The FDA has issued a warning that Ondansetron may increase the risk of developing prolongation of the QT interval, which can lead to an abnormal and potentially fatal heart rhythm, including Torsade de Pointes. Read the rest of this entry »
